Detalles de la búsqueda
1.
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet;
403(10429): 813-823, 2024 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38387470
2.
The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study.
BMC Public Health;
23(1): 1875, 2023 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37770829
3.
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
Lancet Infect Dis;
2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38614117
4.
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial.
Lancet Infect Dis;
23(11): 1313-1322, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37475116
5.
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial.
Sci Bull (Beijing);
68(20): 2448-2455, 2023 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743201
6.
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Respir Med;
11(12): 1075-1088, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37979588
7.
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
Emerg Microbes Infect;
11(1): 793-803, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35195494
Resultados
1 -
7
de 7
1
Próxima >
>>